Editas Medicine, Inc. Annual Operating Lease, Payments in USD from 2019 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Editas Medicine, Inc. annual/quarterly Operating Lease, Payments history and growth rate from 2019 to 2024.
  • Editas Medicine, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $3.85M, a 1.28% decline year-over-year.
  • Editas Medicine, Inc. annual Operating Lease, Payments for 2024 was $18.4M, a 48.4% increase from 2023.
  • Editas Medicine, Inc. annual Operating Lease, Payments for 2023 was $12.4M, a 16.3% decline from 2022.
  • Editas Medicine, Inc. annual Operating Lease, Payments for 2022 was $14.9M, a 13.4% increase from 2021.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $18.4M +$6.02M +48.4% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-05
2023 $12.4M -$2.42M -16.3% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-05
2022 $14.9M +$1.76M +13.4% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-05
2021 $13.1M +$3.33M +34.2% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $9.76M +$3.79M +63.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-22
2019 $5.97M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.